DIRECTOR DEALINGS: Hikma Non-Executive Director Buys First Shares

Tue, 12th Apr 2016 09:48

LONDON (Alliance News) - Hikma Pharmaceuticals PLC Tuesday said Non-Executive Director John Castellani bought 2,500 shares at 2,103 pence each on Monday.

The purchase is Castellani's only holding in the FTSE 250 company after being appointed in February. He was president and chief executive officer of the Pharmaceutical Research & Manufacturers of America from 2010 to 2015.

Shares in the Jordan-founded drug maker were up 0.1% at 2,145.00p Tuesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Related Shares

More News

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 10:15

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

25 Apr 2024 08:01

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...